7-(HETEROARYL-AMINO)-6,7,8,9-TETRAHYDROPYRIDO[1,2-A]INDOL ACETIC ACID DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS

IPC classification:

A61K 31/437, A61P 37/08, C07D 471/04

Applicant:

Actelion Pharmaceuticals Ltd.

Agent:

Ralf Koberstein, Actelion Pharmaceuticals Ltd.

Status:

█ PATENT GRANTED

HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS

IPC classification:

A61K 31/4355, A61K 31/436, A61P 29/00, C07D 491/048, C07D 491/052

Applicant:

Actelion Pharmaceuticals Ltd.

Agent:

Ralf Koberstein, Actelion Pharmaceuticals Ltd.

Status:

█ NO OPPOSITION FILED WITHIN TIMELIMIT

HETEROCYCLYL DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS

IPC classification:

A61K 31/47, C07D 209/44, C07D 217/06, C07D 223/06, C07D 223/16, C07D 401/06, C07D 401/12, C07D 405/06, C07D 413/06, C07D 417/06

Applicant:

Actelion Pharmaceuticals Ltd.

Agent:

Ralf Koberstein, Actelion Pharmaceuticals Ltd.

Status:

█ PATENT GRANTED

HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS

IPC classification:

A61K 31/4355, A61P 29/00, C07D 491/048

Applicant:

Actelion Pharmaceuticals Ltd.

Agent:

Ralf Koberstein, Actelion Pharmaceuticals Ltd.

Status:

█ NO OPPOSITION FILED WITHIN TIMELIMIT

4-(BENZOIMIDAZOL-2-YL)-THIAZOLE COMPOUNDS AND RELATED AZA DERIVATIVES

IPC classification:

A61K 31/427, C07D 417/14, C07D 471/04, C07D 487/04, C07D 519/00

Applicant:

Actelion Pharmaceuticals Ltd.

Agent:

Ralf Koberstein, Actelion Pharmaceuticals Ltd.

Status:

█ PATENT GRANTED

1-(P-TOLYL)CYCLOPROPYL SUBSTITUTED BRIDGED SPIRO[2.4]HEPTANE DERIVATIVES AS ALX RECEPTOR AGONISTS

IPC classification:

A61K 31/40, A61P 3/00, C07D 207/08, C07D 207/10

Applicant:

Actelion Pharmaceuticals Ltd.

Agent:

Ralf Koberstein, Actelion Pharmaceuticals Ltd.

Status:

█ PATENT GRANTED

FLUORINATED BRIDGED SPIRO[2.4]HEPTANE DERIVATIVES AS ALX RECEPTOR AGONISTS

IPC classification:

A61K 31/40, A61K 31/44, A61P 9/00, A61P 29/00, A61P 31/12, C07D 207/34, C07D 211/58

Applicant:

Actelion Pharmaceuticals Ltd.

Agent:

Ralf Koberstein, Actelion Pharmaceuticals Ltd.

Status:

█ PATENT GRANTED

1-PHENYL-SUBSTITUTED HETEROCYCLYL DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS

IPC classification:

A61K 31/4353, A61P 11/00, A61P 17/00, A61P 37/00, C07D 513/04

Applicant:

Actelion Pharmaceuticals Ltd.

Agent:

Ralf Koberstein, Actelion Pharmaceuticals Ltd.

Status:

█ EXAMINATION IN PROGRESS

INDOLE CARBOXAMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS

IPC classification:

A61K 31/405, A61K 31/506, A61P 11/00, A61P 19/00, A61P 25/28, C07D 209/08, C07D 401/12, C07D 401/14, C07D 403/12, C07D 403/14, C07D 405/14, C07D 413/12, C07D 413/14, C07D 417/12, C07D 498/08

Applicant:

Actelion Pharmaceuticals Ltd.

Agent:

Ralf Koberstein, Actelion Pharmaceuticals Ltd.

Status:

█ PATENT GRANTED

INDOLE CARBOXAMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS

IPC classification:

A61K 31/404, A61P 29/00, C07D 209/08, C07D 209/24

Applicant:

Actelion Pharmaceuticals Ltd.

Agent:

Ralf Koberstein, Actelion Pharmaceuticals Ltd.

Status:

█ PATENT GRANTED

HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS

IPC classification:

A61K 31/428, A61K 31/429, A61P 29/00, C07D 277/60, C07D 513/04

Applicant:

Actelion Pharmaceuticals Ltd.

Agent:

Ralf Koberstein, Actelion Pharmaceuticals Ltd.

Status:

█ PATENT GRANTED

HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS& xA;

IPC classification:

A61K 31/428, A61K 31/429, A61P 25/00, A61P 29/00, C07D 277/60

Applicant:

Actelion Pharmaceuticals Ltd.

Agent:

Ralf Koberstein, Actelion Pharmaceuticals Ltd.

Status:

█ PATENT GRANTED

DIFLUOROETHYL-OXAZOLE SUBSTITUTED BRIDGED SPIRO[2.4]HEPTANE DERIVATIVES AS ALX RECEPTOR AGONISTS

IPC classification:

A61K 31/422, C07D 413/12

Applicant:

Actelion Pharmaceuticals Ltd.

Agent:

Ralf Koberstein, Actelion Pharmaceuticals Ltd.

Status:

█ PATENT GRANTED

PIPERAZINE SUBSTITUTED BRIDGED SPIRO[2.4]HEPTANE DERIVATIVES AS ALX RECEPTOR AGONISTS

IPC classification:

A61K 31/495, C07D 295/14

Agent:

Ralf Koberstein, Actelion Pharmaceuticals Ltd.

Status:

█ GRANT OF PATENT INTENDED

BENZIMIDAZOLYL-METHYL UREA DERIVATIVES AS ALX RECEPTOR AGONISTS

IPC classification:

A61K 31/4184, A61P 29/00, C07D 235/14, C07D 401/12, C07D 403/12, C07D 405/12, C07D 413/12, C07D 417/12, C07D 453/02, C07D 471/04, C07D 473/00

Agent:

Ralf Koberstein, Actelion Pharmaceuticals Ltd.

Status:

█ PATENT GRANTED

AZAINDOLE ACETIC ACID DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS

IPC classification:

A61K 31/437, A61P 37/00, C07D 471/04

Applicant:

Actelion Pharmaceuticals Ltd.

Agent:

Ralf Koberstein, Actelion Pharmaceuticals Ltd.

Status:

█ EXAMINATION REQUESTED

AZAINDOLE ACETIC ACID DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS

IPC classification:

A61K 31/437, A61P 37/00, C07D 471/04

Agent:

Ralf Koberstein, Actelion Pharmaceuticals Ltd.

Status:

█ EXAMINATION REQUESTED

8-(PIPERAZIN-1-YL)-1,2,3,4-TETRAHYDRO-ISOQUINOLINE DERIVATIVES

IPC classification:

A61K 31/4725, A61P 25/28, A61P 35/00, A61P 37/00, C07D 401/14, C07D 413/14, C07D 417/14, C07D 471/04

Agent:

Ralf Koberstein, Actelion Pharmaceuticals Ltd.

Status:

█ EXAMINATION REQUESTED

PYRAZOLE COMPOUNDS AND THEIR USE AS T-TYPE CALCIUM CHANNEL BLOCKERS

IPC classification:

A61K 31/415, A61K 31/4155, A61K 31/4439, A61P 3/10, A61P 9/00, A61P 15/00, A61P 25/00, A61P 35/00, C07D 231/40, C07D 401/06, C07D 401/12, C07D 401/14, C07D 403/12, C07D 405/12, C07D 405/14, C07D 413/12, C07D 471/04

Applicant:

Actelion Pharmaceuticals Ltd.

Agent:

Ralf Koberstein, Actelion Pharmaceuticals Ltd.

Status:

█ EXAMINATION REQUESTED

TRIAZOLE COMPOUNDS AS T-TYPE CALCIUM CHANNEL BLOCKERS

IPC classification:

A61K 31/4192, A61P 9/00, A61P 35/00, C07D 249/04, C07D 401/12, C07D 403/12, C07D 405/12

Agent:

Ralf Koberstein, Actelion Pharmaceuticals Ltd.

Agent:

Ralf Koberstein, Idorsia Pharmaceuticals Ltd

Status:

█ Request for examination was made